Home › NDC Lookup › RxCUI directory › RxCUI 1431235

Lurasidone hydrochloride 60 MG Oral Tablet — RxCUI 1431235

RxNorm drug concept · Semantic clinical drug
RxCUI 1431235 Semantic clinical drug · SCD ● Current RxNorm concept 118 FDA products 310 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1431235
Official nameLurasidone hydrochloride 60 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslurasidone HCl 60 MG Oral Tablet
FDA products mapped118
Package NDCs mapped310
Reported Medicaid activity (SDUD)985,250 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lurasidone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, food really does matter here. Taking lurasidone with a meal of at least 350 calories more than doubles the amount of medication your body actually absorbs — so if you take it...
  • Why do I have to take lurasidone with food? Does it matter what I eat?
  • The most common things people notice are sleepiness, nausea, and a restless feeling called akathisia — where you feel like you need to keep moving or can't sit still. These are usu...
  • What side effects should I actually expect, and which ones do I need to call my doctor about?
📖 Read our full Lurasidone guide →

🕸️ Concept Web — How Lurasidone hydrochloride 60 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lurasidone hydrochloride 60 MG Oral Tablet RxCUI 1431235

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Lurasidone 1040028
    • Lurasidone hydrochloride 1040027
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Latuda 1040032
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lurasidone Oral Tablet 1040030
    • Lurasidone hydrochloride Oral Tablet 2646482
    • Lurasidone Oral Product 1163847
    • Lurasidone Pill 1163848
    • Lurasidone hydrochloride Oral Product 2662649
    • Lurasidone hydrochloride Pill 2661024
    • Lurasidone Oral Tablet [Latuda] 1040035
    • Lurasidone hydrochloride Oral Tablet [Latuda] 2656782
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lurasidone hydrochloride 60 MG SCDC · 1431234
  • Lurasidone Oral Tablet SCDF · 1040030
  • Lurasidone hydrochloride Oral Tablet SCDFP · 2646482
  • Lurasidone Oral Product SCDG · 1163847
  • Lurasidone Pill SCDG · 1163848
  • Lurasidone hydrochloride Oral Product SCDGP · 2662649
  • Lurasidone hydrochloride Pill SCDGP · 2661024

Brand-Name Concepts

  • Lurasidone hydrochloride 60 MG Oral Tablet [Latuda] SBD · 1431237
  • Lurasidone hydrochloride 60 MG [Latuda] SBDC · 1431236
  • Lurasidone Oral Tablet [Latuda] SBDF · 1040035
  • Lurasidone hydrochloride Oral Tablet [Latuda] SBDFP · 2656782
  • Latuda Oral Product SBDG · 1176248
  • Latuda Pill SBDG · 1176249
  • Latuda BN · 1040032

📦 FDA Products & Package NDCs

118 products · 310 package NDCs
310 package NDCs map to RxCUI 1431235 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72205-0211-90 90 TABLET, FILM COATED in 1 BOTTLE (72205-211-90) lurasidone hydrochloride Novadoz Pharmaceuticals LLC 2023-02-20
72603-0621-01 30 TABLET, FILM COATED in 1 BOTTLE (72603-621-01) lurasidone hydrochloride NorthStar RxLLC 2025-04-08
72603-0622-01 30 TABLET, FILM COATED in 1 BOTTLE (72603-622-01) lurasidone hydrochloride NorthStar RxLLC 2025-04-08
72603-0623-01 30 TABLET, FILM COATED in 1 BOTTLE (72603-623-01) lurasidone hydrochloride NorthStar RxLLC 2025-04-08
72603-0624-01 30 TABLET, FILM COATED in 1 BOTTLE (72603-624-01) lurasidone hydrochloride NorthStar RxLLC 2025-04-08
76282-0522-30 30 TABLET, FILM COATED in 1 BOTTLE (76282-522-30) Lurasidone Hydrochloride Exelan Pharmaceuticals Inc. 2023-02-20
76282-0523-30 30 TABLET, FILM COATED in 1 BOTTLE (76282-523-30) Lurasidone Hydrochloride Exelan Pharmaceuticals Inc. 2023-02-20
76282-0524-30 30 TABLET, FILM COATED in 1 BOTTLE (76282-524-30) Lurasidone Hydrochloride Exelan Pharmaceuticals Inc. 2023-02-20
76282-0525-30 30 TABLET, FILM COATED in 1 BOTTLE (76282-525-30) Lurasidone Hydrochloride Exelan Pharmaceuticals Inc. 2023-02-20
76282-0534-30 30 TABLET, FILM COATED in 1 BOTTLE (76282-534-30) Lurasidone Hydrochloride Exelan Pharmaceuticals Inc. 2023-02-20
Observed labelers: Alembic Pharmaceuticals Inc. (25) · Alembic Pharmaceuticals Limited (25) · Sumitomo Pharma America, Inc. (25) · Zydus Lifesciences Limited (25) · Zydus Pharmaceuticals USA Inc. (25) · Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc. (21) · +18 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.